Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,494 papers from all fields of science
Search
Sign In
Create Free Account
S 640-P
Known as:
S-640P
, S640P
, S 640 P
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Cefatrizine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
最近臨床材料から分離した各種病原細菌のCefatrizine (S-640P) 感受性について
望 小酒井
,
小栗 豊子
1976
Corpus ID: 82494571
1976
1976
Absorption and excretion of cefatrizine (S-640P) in mouse and rat
M. Matsuzaki
,
K. Nakamura
,
Y. Hirata
,
H. Matsumoto
,
K. Ochiai
1976
Corpus ID: 91093610
1976
1976
Cefatrizine (S-640P) の吸収・排泄に関する研究
明紀 松崎
,
浩良 松本
,
+4 authors
実 関野
1976
Corpus ID: 88818774
1976
1976
[Metabolism of cefatrizine (S-640P) in rat, rabbit, dog, monkey and human (author's transl)].
M. Matsuzaki
,
M. Ohtawa
,
I. Akiyama
,
M. Yamamato
,
J. Tomioka
The Japanese Journal of Antibiotics
1976
Corpus ID: 35388799
1976
1976
[Immunological studies of cefatrizine (S-640P) (author's transl)].
M. Matsuzaki
,
T. Kamei
,
Y. Furutani
,
S. Akutsu
The Japanese Journal of Antibiotics
1976
Corpus ID: 35249406
1976
1976
皮膚科領域におけるCefatrizine (S-640P)
荒田 次郎
,
谷奥 喜平
1976
Corpus ID: 82906952
1976
1976
Cefatrizine(S-640P)に関する免疫学的研究
松崎 明紀
,
亀井 敏夫
,
古谷 幸子
,
貞夫 阿久津
1976
Corpus ID: 209532297
1976
1976
Cefatrizine (S-640P) に関する細菌学的研究
M. Matsuzaki
,
N. Tado
,
Y. Hirata
,
M. Kato
,
K. Nakumura
1976
Corpus ID: 86842904
1976
1976
[Teratological studies of cefatrizine (S-640P) in mice and rats III (author's transl)].
M. Matsuzaki
,
S. Akutsu
,
T. Shimamura
,
H. Honda
The Japanese Journal of Antibiotics
1976
Corpus ID: 34437532
1976
1976
小児科領域におけるCefatrizine (S-640P) Dry Syrupに関する基礎的, 臨床的研究
小林 裕
,
森川 嘉郎
,
春田 恒和
1976
Corpus ID: 83029689
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE